— Know what they know.
Not Investment Advice

688266.SS SHH

Suzhou Zelgen Biopharmaceuticals Co., Ltd.
1W: -7.2% 1M: -6.5% 3M: -19.3% YTD: +14.6% 1Y: +3.6% 3Y: +131.0% 5Y: +46.2%
¥110.00 ($16.40)
+3.34 (+3.13%)
 
SHH · Healthcare · Biotechnology · Tech Score Sell · Power 36 · ¥29.1B mcap · 221M float · 2.92% daily turnover

📊 Key Metrics

TTM
¥2B
Revenue
+145.6% YoY
¥552M
Net Income
+483.2% YoY
¥770M
Free Cash Flow
+457.3% YoY
84.9%
Gross Margin
-6.5%
Op. Margin
2.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE38.1%
ROA16.9%
ROIC511.8%

Valuation

P/E53.0
P/B16.9
EV/EBITDA53.1

Leverage

Debt/Equity0.50
Current Ratio2.50
Interest Cov.23.5x

Quality Scores

Piotroski F7/9
Altman Z11.20
Beneish M-2.83

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms